Owners, management and financials
CVR: 36033347
Secondary names: GxP Pharma Support ApS, GxP Pharma ApS, GxP Support ApS
Previous names: GXP-PHARMA SUPPORT A/S
DKK 128,518
Gross profit
Net result: DKK -314,498
CHRIBEN ApS (100%)
CVR · view owners
Lone Cleveland Andersen
Board: Jan Laursen (chair) and 2 members
CVR · view management
Active
Founded 3 July 2014
CVR · view overview
1 employee
CVR · 2026
Name registered: GXP-PHARMA SUPPORT ApS
CVR · 30/04/2025
View the full event history
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The board consists of Jan Laursen (chair), Iben Cleveland Laursen and Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.
Selskabets formål er salg og udvikling af undervisning, konsulentassistance og inspektioner indenfor det farmaceutiske område og anden efter ledelsen relevant beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 129 t. | -314 t. | 198 t. | 59 t. | 1 | |
| 202401/01/2024 – 31/12/2024 | -263 t. | -166 t. | 646 t. | 373 t. | 1 | |
| 202301/01/2023 – 31/12/2023 | 361 t. | 367 t. | 1.5 mio. | 1.1 mio. | 1 | |
| 202201/01/2022 – 31/12/2022 | 211 t. | -346 t. | 1.1 mio. | 772 t. | 1 | |
| 202101/01/2021 – 31/12/2021 | 1.1 mio. | 426 t. | 2.2 mio. | 1.1 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | 1 mio. | 664 t. | 4 mio. | 1.7 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | 1.2 mio. | 328 t. | 2.9 mio. | 1.4 mio. | - | |
| 201801/01/2018 – 31/12/2018 | 1.5 mio. | 28 t. | 1.8 mio. | 1.1 mio. | - | |
| 201701/01/2017 – 31/12/2017 | 1.1 mio. | 424 t. | 3.2 mio. | 1.9 mio. | - | |
| 201601/01/2016 – 31/12/2016 | 1.5 mio. | 154 t. | 2.5 mio. | 1.4 mio. | - |
Compared to 1.487 companies in Anden teknisk rådgivning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of GXP-PHARMA SUPPORT ApS is 36033347.
GXP-PHARMA SUPPORT ApS is owned by CHRIBEN ApS.
The management of GXP-PHARMA SUPPORT ApS consists of Lone Cleveland Andersen.
The board of GXP-PHARMA SUPPORT ApS consists of Jan Laursen, Iben Cleveland Laursen and Lone Cleveland Andersen, with Jan Laursen as chair.
In 2025, GXP-PHARMA SUPPORT ApS reported a gross profit of DKK 128,518.
GXP-PHARMA SUPPORT ApS had 1 employee in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
GXP-PHARMA SUPPORT ApS has published its annual report for 2025. Gross profit came to DKK 128,518, and the net result was DKK -314,498.
Contact info changed: new phone: 50300270, new email: [email protected], new website: www.gxp-pharmasupport.dk (March 20, 2026).
On April 30, 2025, the company changed its name from GXP-PHARMA SUPPORT A/S to GXP-PHARMA SUPPORT ApS.
GXP-PHARMA SUPPORT ApS has published its annual report for 2024. Gross profit came to DKK -262,786, and the net result was DKK -166,431.
GXP-PHARMA SUPPORT ApS has published its annual report for 2023. Gross profit came to DKK 360,871, and the net result was DKK 367,356.
GXP-PHARMA SUPPORT ApS has published its annual report for 2022. Gross profit came to DKK 211,195, and the net result was DKK -345,549.
GXP-PHARMA SUPPORT ApS has published its annual report for 2021. Gross profit came to DKK 1,094,653, and the net result was DKK 425,670.
GXP-PHARMA SUPPORT ApS has published its annual report for 2020. Gross profit came to DKK 1,000,079, and the net result was DKK 664,083.
GXP-PHARMA SUPPORT ApS has published its annual report for 2019. Gross profit came to DKK 1,167,811, and the net result was DKK 328,406.
GXP-PHARMA SUPPORT ApS has published its annual report for 2018. Gross profit came to DKK 1,517,034, and the net result was DKK 28,043.
As of May 10, 2019, AIDER Slagelse og Nyborg Godkendt Revisionsaktieselskab has stepped down as auditor of GXP-PHARMA SUPPORT ApS.
GXP-PHARMA SUPPORT ApS has published its annual report for 2017. Gross profit came to DKK 1,084,666, and the net result was DKK 423,986.
GXP-PHARMA SUPPORT ApS has published its annual report for 2016. Gross profit came to DKK 1,450,436, and the net result was DKK 153,689.
GXP-PHARMA SUPPORT ApS has published its interim report for the period July 3, 2014 to December 31, 2015.
As of July 3, 2014, AIDER Slagelse og Nyborg Godkendt Revisionsaktieselskab has been appointed auditor of GXP-PHARMA SUPPORT ApS.
As of July 3, 2014, Jan Laursen has joined the board of directors of GXP-PHARMA SUPPORT ApS.
As of July 3, 2014, Lone Cleveland Andersen has joined the board of directors of GXP-PHARMA SUPPORT ApS.
As of July 3, 2014, Iben Cleveland Laursen has joined the board of directors of GXP-PHARMA SUPPORT ApS.
As of July 3, 2014, Lone Cleveland Andersen is registered as adm. dir. of GXP-PHARMA SUPPORT ApS.
As of July 3, 2014, CHRIBEN ApS is registered as an owner of GXP-PHARMA SUPPORT ApS with an ownership share of 100%.
GXP-PHARMA SUPPORT ApS was founded on July 3, 2014.
Companies in the same industry and area
CVR 40632360
CVR 43958224
CVR 35832971
CVR 41133708
CVR 43870157
